Originator Organization Teon Therapeutics, Inc.Startup |
Active Organization- |
Inactive Organization Teon Therapeutics, Inc.Startup |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | Teon Therapeutics, Inc.Startup | 10 Dec 2019 |